CAS: 82209-76-5 - (2R,5S,6S,12E,14S)-17-(beta-D-glucopyranosyloxy)-2,14-dihydroxy-20-oxo-9,19-didehydro-5,6,7,8,9,10,11,14,15-decahydro-20:5,10-dicycloretinal
Formel:C26H40O10
InChl:InChI=1/C26H40O10/c1-13-4-7-18-25(2,15(13)6-5-14-16(28)11-34-23(14)33)9-8-19(29)26(18,3)12-35-24-22(32)21(31)20(30)17(10-27)36-24/h5,15-22,24,27-32H,1,4,6-12H2,2-3H3/b14-5+/t15?,16-,17-,18+,19-,20-,21+,22-,24-,25+,26+/m1/s1
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
andrographoside REF: IN-DA00G66ICAS: 82209-76-5 | 96.0% | Nachfragen | Fr 03 Jan 25 | |
Andrographiside REF: TM-TN3412CAS: 82209-76-5 | 98% | Nachfragen | Di 07 Jan 25 | |
Andrographiside REF: 7W-GL2406CAS: 82209-76-5 | - - - | Nachfragen | Di 07 Jan 25 | |
Andrographiside REF: BP-SBP02520CAS: 82209-76-5 | 95%~99% | Nachfragen | Di 07 Jan 25 | |
Andrographiside REF: 3D-HDA20976CAS: 82209-76-5 | Min. 95% | Nachfragen | Fr 14 Feb 25 |
Ref: IN-DA00G66I
5mg | Nachfragen |
Andrographiside
Ref: TM-TN3412
5mg | 508,00 € | ||
1mL*10mM (DMSO) | 771,00 € |
Ref: 7W-GL2406
Unbestimmte Größe | Nachfragen |
Ref: BP-SBP02520
Unbestimmte Größe | Nachfragen |
Andrographiside
Ref: 3D-HDA20976
5mg | Nachfragen | ||
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen |